Complex regulation of ADAR-mediated RNA-editing across tissues

BMC Genomics

Volumn 17, Issue 1, 2016, Pages

  Huntley, Melanie A ^a   Lou, Melanie ^a   Goldstein, Leonard D ^a   Lawrence, Michael ^a   Dijkgraaf, Gerrit J P ^a   Kaminker, Joshua S ^a   Gentleman, Robert ^a  

^a GENENTECH INC   (United States)

Author keywords

ADAR; RNA DNA difference; RNA editing

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; DNA TRANSCRIPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; INTRON; MOUSE; NONHUMAN; RNA EDITING; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BRAIN; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM;

ADAR1 PROTEIN, MOUSE; ADAR2 PROTEIN, MOUSE; ADENOSINE DEAMINASE; ISOPROTEIN; RNA BINDING PROTEIN;

ADENOSINE DEAMINASE; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; INTRONS; MICE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RNA EDITING; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84954304766     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-2291-9     Document Type: Article

References (53)

1. Gott JM, Emeson RB. Functions and mechanisms of RNA editing. Annu Rev Genet. 2000; 34:499-531.
2. Polson AG, Crain PF, Pomerantz SC, McCloskey JA, Bass BL. The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: a high-performance liquid chromatography-mass spectrometry analysis. Biochemistry. 1991; 30:11507-14.
3. Savva YA, Rieder LE, Reenan RA. The ADAR protein family. Genome Biol. 2012; 13:252-2012.
4. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem. 2002; 71:817-46.
5. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49.
6. Sommer B, Kohler M, Sprengel R, Seeburg PH. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell. 1991; 67:11-9.
7. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura KA. third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA. 2000; 6:755-67.
8. George CX, Samuel CE. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A. 1999; 96:4621-6.
9. Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol. 1995; 15:5376-88.
10. Poulsen H, Nilsson J, Damgaard CK, Egebjerg J, Kjems J. CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol Cell Biol. 2001; 21:7862-71.
11. Seeburg PH, Hartner J. Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr Opin Neurobiol. 2003; 13:279-83.
12. Valente L, Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol. 2005; 79:299-338.
13. Toth AM, Zhang P, Das S, George CX, Samuel CE. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol. 2006; 81:369-434.
14. George CX, Gan Z, Liu Y, Samuel CE. Adenosine deaminases acting on RNA, RNA editing, and interferon action. J Interferon Cytokine Res. 2011; 31:99-117.
15. Osenberg S, Dominissini D, Rechavi G, Eisenberg E. Widespread cleavage of A-to-I hyperediting substrates. RNA. 2009; 15:1632-9.
16. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature. 2000; 406:78-81.
17. Jin Y, Zhang W, Li Q. Origins and evolution of ADAR-mediated RNA editing. IUBMB Life. 2009; 61:572-8.
18. Jepson JE, Savva YA, Yokose C, Sugden AU, Sahin A, Reenan RA. Engineered alterations in RNA editing modulate complex behavior in Drosophila: regulatory diversity of adenosine deaminase acting on RNA (ADAR) targets. J Biol Chem. 2011; 286:8325-37.
19. Maas S, Kawahara Y, Tamburro KM, Nishikura K. A-to-I RNA editing and human disease. RNA Biol. 2006; 3:1-9.
20. Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, et al. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet. 2003; 73:693-9.
21. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet. 2012; 44:1243-8.
22. Chen L. Characterization and comparison of human nuclear and cytosolic editomes. Proc Natl Acad Sci U S A. 2013; 110:E2741-7.
23. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007; 17:1586-95.
24. Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, et al. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 2015; 13:267-76.
25. Han L, Diao L, Yu S, Xu X, Li J, Zhang R, et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell. 2015; 28:515-28.
26. Danecek P, Nellaker C, McIntyre RE, Buendia-Buendia JE, Bumpstead S, Ponting CP, et al. High levels of RNA-editing site conservation amongst 15 laboratory mouse strains. Genome Biol. 2012; 13:26-2012.
27. Dillman AA, Hauser DN, Gibbs JR, Nalls MA, McCoy MK, Rudenko IN, et al. mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. Nat Neurosci. 2013; 16:499-506.
28. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science. 2009; 324:1210-3.
29. Kiran AM, O'Mahony JJ, Sanjeev K, Baranov PV. Darned in 2013: inclusion of model organisms and linking with Wikipedia. Nucleic Acids Res. 2013; 41:D258-61.
30. Ramaswami G, Li JB. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res. 2014; 42:D109-13.
31. Hoopengardner B, Bhalla T, Staber C, Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science. 2003; 301:832-6.
32. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 1997; 387:303-8.
33. Ohlson J, Pedersen JS, Haussler D, Ohman M. Editing modifies the GABA(A) receptor subunit alpha3. RNA. 2007; 13:698-703.
34. Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB. Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci. 2008; 28:6196-201.
35. Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. FASEB J. 2008; 22:2888-900.
36. Wahlstedt H, Daniel C, Enstero M, Ohman M. Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res. 2009; 19:978-86.
37. Lee JH, Ang JK, Xiao X. Analysis and design of RNA sequencing experiments for identifying RNA editing and other single-nucleotide variants. RNA. 2013; 19:725-32.
38. Zhang Q, Xiao X. Genome sequence-independent identification of RNA editing sites. Nat Methods. 2015; 12:347-50.
39. Chen JY, Peng Z, Zhang R, Yang XZ, Tan BC, Fang H, et al. RNA editome in rhesus macaque shaped by purifying selection. PLoS Genet. 2014:;10.
40. Braunschweig U, Barbosa-Morais NL, Pan Q, Nachman EN, Alipanahi B, Gonatopoulos-Pournatzis T, et al. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014; 24:1774-86.
41. Sibley CR, Emmett W, Blazquez L, Faro A, Haberman N, Briese M, et al. Recursive splicing in long vertebrate genes. Nature. 2015; 521:371-5.
42. Neeman Y, Levanon EY, Jantsch MF, Eisenberg E. RNA editing level in the mouse is determined by the genomic repeat repertoire. RNA. 2006; 12:1802-9.
43. Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut. 2014; 63:832-43.
44. Jaikaran DC, Collins CH, MacMillan AM. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site. J Biol Chem. 2002; 277:37624-9.
45. Cho DS, Yang W, Lee JT, Shiekhattar R, Murray JM, Nishikura K. Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA. J Biol Chem. 2003; 278:17093-102.
46. Gallo A, Keegan LP, Ring GM, O'Connell MA. An ADAR that edits transcripts encoding ion channel subunits functions as a dimer. EMBO J. 2003; 22:3421-30.
47. Chilibeck KA, Wu T, Liang C, Schellenberg MJ, Gesner EM, Lynch JM, et al.FRET analysis of in vivo dimerization by RNA-editing enzymes. J Biol Chem. 2006; 281:16530-5.
48. Poulsen H, Jorgensen R, Heding A, Nielsen FC, Bonven B, Egebjerg J. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA. 2006; 12:1350-60.
49. Valente L, Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem. 2007; 282:16054-61.
50. Brawand D, Soumillon M, Necsulea A, Julien P, Csardi G, Harrigan P, et al. The evolution of gene expression levels in mammalian organs. Nature. 2011; 478:343-8.
51. Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics. 2010; 26:873-81.
52. Pau G, Reeder J. HTSeqGenie: A NGS analysis pipeline. R package. 2013.
53. Lawrence M, Degenhardt J, Gentleman R. VariantTools: Tools for Working with Genetic Variants. R package. 2013.